HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein

Abstract

Background and Aims Cancer is typically considered as a genetic and epigenetic disease. Although numerous studies have indicated that an aberrant structure, function, or expression level of epigenetic enzymes contribute to many tumor types, precisely how the epigenetic mechanisms are involved in the hepatitis B virus (HBV)‐induced hepatocellular carcinoma (HCC) remains unknown. Approach and Results In this study, we found that the WD repeat domain 5 protein (WDR5)—a core subunit of histone H3 lysine 4 methyltransferase complexes, which catalyze the generation of histone H3 lysine 4 trimethylation (H3K4me3) modification—is highly expressed in HBV‐related HCC and promotes HCC development. WDR5 plays a critical role in HBV‐driven cell proliferation and tumor growth in mice, and the WDR5‐0103 small‐molecule inhibitor of WDR5 activity compromises HBV‐ and hepatitis B x protein (HBx)‐driven tumor proliferation. The aberrantly high WDR5 protein level was found to involve HBx through its stabilization of the WDR5 protein by inhibiting the interaction between the damage‐specific DNA‐binding protein 1/cullin‐4 and WDR5, causing decreased ubiquitination of the WDR5 protein. HBx was found to colocalize with WDR5 on chromatin genome wide and promotes genome‐wide H3K4me3 modification by means of WDR5. Furthermore, the recruitment of HBx to promoters of target genes relied on its interaction with WDR5 through its α‐helix domain. WDR5 was also found to promote HBV transcription through H3K4 modification of covalently closed circular DNA minichromosome, and WDR5‐0103 was able to inhibit HBV transcription. Finally, the in vitro and in vivo data further proved that HBx exerted its tumor‐promoting function in a WDR5‐dependent manner. Conclusions Our data reveals that WDR5 is a key epigenetic determinant of HBV‐induced tumorigenesis and that the HBx‐WDR5‐H3K4me3 axis may be a potential therapeutic target in HBV‐induced liver pathogenesis.

HBx‐upregulated MAFG‐AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA

“…3 HBV is a DNA virus that encodes four proteins, including the transcriptional cofactor HBx. 4 Recent studies indicate that HBx not only regulates protein expression, 5,6 but also influences the transcription of long noncoding RNAs (lncRNAs). 7,8 LncRNAs are divided into four categories, 9 including guide lncRNAs, 10,11 decoy lncRNAs, 12,13 scaffold ln-cRNAs, 14,15 and signal lncRNAs.…”

ViMIC: A Database of Human Disease-related Virus Mutations, Integration Sites and Cis-effects

“…Some virus mutations (VMs) may play an important role in promoting the occurrence of diseases by increasing or decreasing the incidence of viral DNA integration into host cells (10)(11)(12)(13). Moreover, alterations in epigenetics may also be induced by the viral protein to promote activation or inhibition of target genes (14)(15)(16)(17).…”

SPP1 Might Be a Novel Prognostic Biomarker for Patients With Malignancy: a Meta-analysis and Sequential Verification Based on Bioinformatic Analysis

“…SPP1 is correlated with histone H3 lysine 4 trimethylation (H3K4me3) as a key regulator [51] . H3K4me3 often leads to transcriptional activation of tumorrelated genes [52] and is linked to tumor progression and poor prognosis in hepatocellular carcinoma, lung cancer, prostate cancer and pancreatic cancer [53][54][55][56] . Additionally, SPP1 expression is stimulated by hypoxia and SPP1 signaling also transcriptionally upregulates the expression of hypoxia markers, enhancing tumor angiogenesis and promoting cancer progression and invasion in breast and melanoma cancer [57,58] .…”